drugset / Trial / NCT07585396

Inositol in Letrozol Resistant PCOS Women

NCT07585396 ↗

Phase 2/3 Completed 136 enrolled Kafrelsheikh University
RandomizedParallel-groupOpen-labelTreatment

Summary

Polycystic ovary syndrome (PCOS),is a complex neuro-endocrine disorder affecting approximately 5% to 10% of women in reproductive age.Inositols are considered insulin sensitizers, as they modulate the members of insulin signaling pathways.Thiss study compares between the effect of inositol and metformin in letrozol resistant PCOS women.

Timeline

Start
2024-04-10
Primary completion
2026-06-10
Completion
2026-07-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Metformin Small molecule 1500 mg Oral
Comparator Myo-inositol Small molecule 2 g Oral